Literature DB >> 9212238

Detection of Epstein-Barr virus small RNAs EBER1 and EBER2 in lymphomas of SIV-infected rhesus monkeys by in situ hybridization.

S Pingel1, H Hannig, K Mätz-Rensing, F J Kaup, G Hunsmann, W Bodemer.   

Abstract

SIV infection of macaques is a well-established animal model for studying the pathogenesis of HIV infection in humans. During the course of SIV infection, up to 40% of cynomolgus macaques (Macaca fascicularis) develop SIV-associated non-Hodgkin's lymphomas. In the present study, we characterized malignant lymphomas of SIV(mac) 251/32H-infected rhesus macaques (Macaca mulatto) of our cohort in terms of clinical outcome, histopathology and EBV association. Histopathologic changes of lymphoid malignancies were classified according to the Kiel classification. For detection of the EBV-encoded small RNAs EBER1 and EBER2, a method of non-isotopic in situ hybridization was established. The presence of EBNA-2 antigens was assessed by immunohistochemistry. Seven of 43 rhesus macaques developed highly malignant B-cell lymphomas of the centroblastic, immunoblastic and Burkitt subtypes within 18-29 months post-experimental SIV infection. In situ hybridization revealed the presence of small EBER1 and -2 RNAs in 6 of 7 disease cases. EBNA-2 antigens could be demonstrated in only 4 of 7 tissue specimens. As expected, the Burkitt-type of lymphoma was negative for EBNA-2 antigen staining. In accordance with findings on SIV-associated lymphomas of cynomolgus macaques, infection with an EBV-related herpesvirus could be demonstrated in almost 90% of lymphomas in SIV-infected rhesus macaques. In contrast, the presence of EBV in lymphomas had been documented previously in only 30-40% of HIV-infected patients. Further studies should thus define the precise role of herpesvirus infection for lymphomagenesis in SIV- and HIV-induced immunodeficiency.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9212238     DOI: 10.1002/(sici)1097-0215(19970703)72:1<160::aid-ijc23>3.0.co;2-m

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Detection of abundantly transcribed genes and gene translocation in human immunodeficiency virus-associated non-Hodgkin's lymphoma.

Authors:  V Tarantul; A Nikolaev; H Hannig; B Kalmyrzaev; I Muchoyan; V Maximov; V Nenasheva; V Dubovaya; G Hunsmann; W Bodemer
Journal:  Neoplasia       Date:  2001 Mar-Apr       Impact factor: 5.715

2.  Comparative pathobiology of macaque lymphocryptoviruses.

Authors:  Angela Carville; Keith G Mansfield
Journal:  Comp Med       Date:  2008-02       Impact factor: 0.982

3.  Macaque homologs of EBV and KSHV show uniquely different associations with simian AIDS-related lymphomas.

Authors:  A Gregory Bruce; Helle Bielefeldt-Ohmann; Serge Barcy; Angela M Bakke; Patrick Lewis; Che-Chung Tsai; Robert D Murnane; Timothy M Rose
Journal:  PLoS Pathog       Date:  2012-10-04       Impact factor: 6.823

4.  Differential gene expression in HIV/SIV-associated and spontaneous lymphomas.

Authors:  V V Nenasheva; A I Nikolaev; A V Martynenko; I B Kaplanskaya; W Bodemer; G Hunsmann; V Z Tarantul
Journal:  Int J Med Sci       Date:  2005-10-01       Impact factor: 3.738

5.  Spontaneous Malignant T Cell Lymphoma in a Young Male Common Marmoset (Callithrix jacchus).

Authors:  Itaru Yamaguchi; Kensuke Myojo; Hiroko Sanada; Eri Sudo; Sayaka Ootsuka; Hiroshi Okumura; Atsuko Takami; Tomomi Yoneshige; Yui Suzuki; Minami Imaizumi; Chie Takada; Naoya Kimoto; Koji Saeki; Katsumi Takaba
Journal:  J Toxicol Pathol       Date:  2013-10-15       Impact factor: 1.628

6.  Mountain gorilla lymphocryptovirus has Epstein-Barr virus-like epidemiology and pathology in infants.

Authors:  Tierra Smiley Evans; Linda J Lowenstine; Kirsten V Gilardi; Peter A Barry; Benard J Ssebide; Jean Felix Kinani; Fred Nizeyimana; Jean Bosco Noheri; Michael R Cranfield; Antoine Mudakikwa; Tracey Goldstein; Jonna A K Mazet; Christine Kreuder Johnson
Journal:  Sci Rep       Date:  2017-07-13       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.